| Literature DB >> 21847646 |
Guido Bertolini1, Carlotta Rossi, Daniele Crespi, Stefano Finazzi, Marco Morandotti, Sandra Rossi, Mario Peta, Martin Langer, Daniele Poole.
Abstract
PURPOSE: Uncertainty about the severity of the A(H1N1) pandemia persists. Information about disease severity can be obtained by investigating intensive care unit (ICU) admissions, especially when historical comparisons can be made with cases of community-acquired pneumonia (CAP).Entities:
Mesh:
Year: 2011 PMID: 21847646 PMCID: PMC7094960 DOI: 10.1007/s00134-011-2339-5
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440
Fig. 1Density function of A(H1N1) cases in Italian ICUs
Baseline characteristics of the patients, and comparison with the Australian and Canadian series
| Italy (GiViTI) | Australia/New Zealand (ANZICS) | Canada | |
|---|---|---|---|
| No. ICUs | 155 | 187 | 38 |
| No. ICU beds | 1,086 | 1,879 | 608 |
| No. patients | 319 | 856 | 168 |
| Study period | October 2009–April 2010 | June–August 2009 | April–August 2009 |
| Type of ICU | Adult (151) pediatric (4) | Adult and pediatric | Adult and pediatric |
| PCR confirmed diagnosis | 94.8% (23 missing) | 84.3% | 96.4% |
| Age (years) | Mean 43.0; SD 19.6; median 44 | Median 40 | Mean 32.3; SD 21.4 |
| <1 | 1.6% | 4%a | |
| 1–4 | 2.8% | 3%a | |
| 5–24 | 13.5% | 2%a | |
| 25–49 | 43.3% | 52%a | |
| 50–64 | 24.5% | 31%a | |
| >64 | 14.4% | 8%a | |
| Female | 42.8% (1 missing) | 52.1% | 67.3% |
| Pregnancy (% on females) | 9.6% (38 missing) | 18.0% | 11.5% |
| Obesity | |||
| BMI > 35 | 11.6% | 28.6% | – |
| BMI > 30 | 22.9% | – | 33.3% |
| Diabetes | 15.4% | 16.0% | 20.8% |
| Asthma/COPD | 32.6% (9 missing) | 32.7% | – |
| Immune suppression | 8.8% (2 missing) | 19.6% | |
| Hematologic malignancy | 8.5% (2 missing) | – | 3.0% |
| Metastatic cancer | 0.7% | – | 0.6% |
| Autoimmune disease | 2.8% (2 missing) | – | 4.8% |
| Cardiac failure | 9.0% | 10.5% | 7.1% |
| Chronic renal failure | 4.3% | – | 7.1% |
| ARDS | 53.0% (2 missing) | 48.8% | – |
ICU intensive care unit, PCR polymerase chain reaction, BMI body mass index, COPD chronic obstructive pulmonary disease, ARDS acute respiratory distress syndrome, SD standard deviation, ANZICS Australian and New Zealand Intensive Care Society
aEstimated from Fig. 2a of Ref. [13]
Management of the patients and outcomes in Italy, Australia, and Canada
| Italy (GiViTI) | Australia/New Zealand (ANZICS) | Canada | |
|---|---|---|---|
| Days from first symptoms to hospital admission | Median 4 | Median 4 | Median 4 |
| IQR 2–6 (22 missing) | IQR 2–7 | IQR 2–7 | |
| Mechanical ventilation | 93.4% (2 missing) | 64.6% | 81.0% |
| Invasive ventilation | 69.2% | – | 76.2% |
| NIV | 45.5% | – | 32.7% |
| ECMO (% of ventilated) | 14.3% (11 missing) | 11.6% | 5.1% |
| iNO (% of ventilated) | 8.6% (11 missing) | – | 16.9% |
| HFO (% of ventilated) | 2.5% (11 missing) | – | 14.7% |
| Pronation (% of ventilated) | 22.5% (11 missing) | – | 3.7% |
| Antivirals | 88.5% (12 missing) | – | 90.5% |
| Antibiotics | 86.6% | – | 98.8% |
| Steroids | 54.5% (18 missing) | 18.4% | 50.6% |
| High dose | 9.4% (18 missing) | – | |
| Low dose | 47.5% (18 missing) | – | |
| ICU stay (days) | Mean 13.2; SD 14.4 | Median 7.4 | Median 12 |
| Median 9; IQR 3–17 (4 missing) | IQR 3.0–16.0 | IQR 5–20 | |
| Hospital stay (days) | Mean 23.5; SD 20.3 | Median 12.3; IQR 6.4–22.1 | – |
| Median 18; IQR 10–30 (22 missing) | |||
| ICU mortality | 17.1% (4 missing) | – | 16.7% |
| Hospital mortality | 20.2% (17 missing) | 16.9% | 17.3% |
NIV noninvasive ventilation, ECMO extracorporeal membrane oxygenation, iNO inhaled nitric oxide, HFO high frequency oscillator, ICU intensive care unit, IQR interquartile range, SD standard deviation, ANZICS Australian and New Zealand Intensive Care Society
Characteristics of patients with A(H1N1) pneumonia, and comparison with those admitted from March 2008 to April 2010 with a non-A(H1N1) CAP, in the subset of 136 ICUs taking part in the Margherita Project since March 2008
| A(H1N1) pneumonia ( | Non-A(H1N1) CAP ( |
| |
|---|---|---|---|
| Age | Mean 48.9; SD 15.5; median 48 | Mean 66.2; SD 16.1; median 70 | <0.001 |
| Female | 43.2% | 36.8% | 0.059 |
| None of the following (excluding asthma) | 35.7% | 26.7% (21 missing) | 0.004 |
| Obesity | |||
| BMI > 35 | 10.8% | 6.6% | 0.020 |
| BMI > 30 | 23.5% | 16.0% (21 missing) | 0.004 |
| Diabetes | 17.4% | 22.4% | 0.087 |
| COPD | 31.9% | 45.4% | <0.001 |
| Asthma | 11.1% | – | – |
| Immune suppression | 9.4% | 4.5% | 0.001 |
| Hematologic malignancy | 9.4% | 4.8% | 0.003 |
| Metastatic cancer | 0.9% | 2.3% | 0.188 |
| Autoimmune disease | 3.3% | 4.5% | 0.417 |
| Cardiac failure | 9.9% | 22.0% | <0.001 |
| Chronic renal failure | 4.2% | 13.9% | <0.001 |
| SAPS II | Mean 37.2; SD 17.3; median 34 | Mean 48.5; SD 18.6; median 46 (4 missing) | <0.001 |
| Infection severity | |||
| Infection/sepsis | 57.4% | 62.6% | |
| Severe sepsis | 30.8% | 20.6% | 0.001 |
| Septic shock | 11.9% (2 missing) | 16.8% | |
| PaO2/FiO2 | |||
| ≥200 | 17.4% | 22.7% | |
| 100–199 | 42.7% | 48.0% | <0.001 |
| <100 | 36.6% | 23.3% (5 missing) | |
| Mechanical ventilation | 98.1% | 95.2% (1 missing) | 0.048 |
| Invasive ventilation | 70.4% | 78.7% (1 missing) | 0.004 |
| NIV | 48.4% | 31.8% (1 missing) | <0.001 |
| Vasoactive drugs | 46.5% | 48.6% (1 missing) | 0.542 |
| Dialysis or CVVH | 2.4% | 2.3% | 0.973 |
| ICU stay (days) | Mean 13.7; SD 14.0; median 10; IQR 4–18 | Mean 11.0; SD 14.7; Median 6; IQR 3–14 (1 missing) | 0.009 |
| ICU mortality | 20.2% | 29.5% (1 missing) | 0.004 |
| Hospital mortality | 22.1% | 38.2% (1 missing) | <0.001 |
SD standard deviation, BMI body mass index, COPD chronic obstructive pulmonary disease, SAPS simplified acute physiology scores, NIV noninvasive ventilation, CVVH continuous venovenous hemodialysis, ICU intensive care unit, IQR interquartile range
Fig. 2ICU occupancy rate over time The light blue line indicates the 2009 seasonal influenza period (January–March). The average weekly occupancy rate was obtained by dividing the number of occupied beds each hour by the total number of beds available in the ICUs, and averaging the hourly rates over the week. This provided a very precise estimate that takes account of patients staying just a few hours in the ICU
Fig. 3Density functions of CAP during the seasonal influenza periods in different years
Fig. 4OR of hospital mortality due to A(H1N1) pneumonia compared with non-A(H1N1) CAP, from different multivariate models, and OR of H1N1 after different adjustments. In the left-hand column the H1N1 OR is adjusted by the only variable specified in the corresponding row, in a bivariate model. In the right-hand column, the H1N1 OR is adjusted by the variable specified in the corresponding row plus all the variables listed before, in a multivariate model. Hence, for example, the third row of the left column gives the odds ratio of H1N1 after adjustment for severity of infection; the same row on the right gives the odds ratio of H1N1 after adjustment for severity of infection, length of stay (LOS) before ICU admission, and SAPS II. In the full model, the OR of H1N1 was not statistically significant (0.88; 95% CI 0.59–1.31; p = 0.52), as shown in the last row of the right column